Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate dose comparison for hemodynamic stability during intubation in adults with type 2 diabetes
ACTRN12614001012662Phase 2Completed
- Sponsor
- dr doaa rashwan
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of magnesium sulfate in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by dr doaa rashwan. Primary endpoints: Systolic arterial blood pressure, Diastolic arterial blood pressure and 1 more. Started Nov 2015; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12614001012662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001012662.